|
TRRAP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.172190E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.013400E-01 |
| Normal-vs-Stage2 |
3.778600E-03 |
| Normal-vs-Stage3 |
2.234500E-04 |
| Normal-vs-Stage4 |
1.092470E-02 |
| Stage1-vs-Stage2 |
5.110200E-02 |
| Stage1-vs-Stage3 |
2.042300E-03 |
| Stage1-vs-Stage4 |
6.792400E-02 |
| Stage2-vs-Stage3 |
7.258200E-01 |
| Stage2-vs-Stage4 |
7.755600E-01 |
| Stage3-vs-Stage4 |
4.755800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.681200E-03 |
| Normal-vs-AfricanAmerican |
1.861370E-01 |
| Normal-vs-Asian |
2.379800E-01 |
| Caucasian-vs-AfricanAmerican |
4.228600E-01 |
| Caucasian-vs-Asian |
4.049700E-02 |
| AfricanAmerican-vs-Asian |
1.207770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.165550E-02 |
| Normal-vs-Female |
2.890500E-02 |
| Male-vs-Female |
4.716800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.778200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.020040E-01 |
| Normal-vs-Age(61-80Yrs) |
3.224700E-03 |
| Normal-vs-Age(81-100Yrs) |
3.233800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.858600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.430600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.179800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.609600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.384060E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.194000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.387200E-01 |
| Normal-vs-Grade 2 |
9.292000E-02 |
| Normal-vs-Grade 3 |
1.135210E-03 |
| Normal-vs-Grade 4 |
9.835600E-03 |
| Grade 1-vs-Grade 2 |
6.445900E-02 |
| Grade 1-vs-Grade 3 |
4.997900E-03 |
| Grade 1-vs-Grade 4 |
2.137600E-02 |
| Grade 2-vs-Grade 3 |
5.972400E-02 |
| Grade 2-vs-Grade 4 |
1.542630E-01 |
| Grade 3-vs-Grade 4 |
8.657600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.215560E-02 |
| Normal-vs-ccB subtype |
8.287600E-02 |
| ccA subtype-vs-ccB subtype |
4.659600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.060150E-02 |
| Normal-vs-N1 |
8.088000E-01 |
| N0-vs-N1 |
5.739400E-01 |
|
|
